Docusol Plus (Enemeez Inc. DBA Summit Pharmaceuticals)
Welcome to the PulseAid listing for the Docusol Plus drug offered from Enemeez Inc. DBA Summit Pharmaceuticals. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Enemeez Inc. DBA Summit Pharmaceuticals |
NON-PROPRIETARY NAME: | docusate sodium w/benzocaine |
SUBSTANCE NAME: | DOCUSATE SODIUM; BENZOCAINE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | RECTAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2013-07-12 |
END MARKETING DATE: | 0000-00-00 |
Docusol Plus HUMAN OTC DRUG Details:
Item Description | Docusol Plus from Enemeez Inc. DBA Summit Pharmaceuticals |
LABELER NAME: | Enemeez Inc. DBA Summit Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 283; 20(mg/5mL; mg/5mL) |
START MARKETING DATE: | 2013-07-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17433-9883_05f5eb41-83d7-4549-e054-00144ff8d46c |
PRODUCT NDC: | 17433-9883 |
APPLICATION NUMBER: | part334 |
Other DOCUSATE SODIUM; BENZOCAINE Pharmaceutical Manufacturers / Labelers: